| Benchmark | Metric | Baseline | This Paper | Δ |
|---|---|---|---|---|
| BraTS 2020 results averaged over 15 missing modality combinations show CLoE outperforms all baselines on all tumor subregions. | ||||
| BraTS 2020 | Dice (Whole Tumor) | 87.54 | 88.09 | +0.55 |
| BraTS 2020 | Dice (Tumor Core) | 79.63 | 80.23 | +0.60 |
| BraTS 2020 | Dice (Enhancing Tumor) | 61.70 | 65.06 | +3.36 |
| Ablation study on BraTS 2020 validates the contribution of each component. | ||||
| BraTS 2020 | Dice (Average) | Not reported in the paper | Not reported in the paper | +1.98 |
| BraTS 2020 | Dice (Average) | Not reported in the paper | Not reported in the paper | +2.47 |
| Prostate dataset results show strong generalization to different organs and modalities. | ||||
| MSD Prostate | Dice (Peripheral Zone) | Not reported in the paper | Not reported in the paper | +2.77 |